Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Temozolomide Stability in Extemporaneously Compounded Oral Suspensions

Author(s):  Trissel Lawrence A, Zhang Yanping, Koontz Susannah E

Issue:  Sep/Oct 2006 - Dermatology
View All Articles in Issue

Abstract:  Temozolomide, commercially available in capsules, is an oral alkylating agent used to treat brain tumors. The purpose of this study was to determine the pharmaceutical acceptability and chemical stability of temozolomide in two extemporaneously compounded suspension formulations prepared from the capsules. The temozolomide oral suspensions were prepared from 100-mg commercial capsules yielding a nominal temozolomide concentration of 10 mg/mL. The suspension vehicles selected for testing were an equal parts mixture of Ora-Plus and Ora-Sweet and an equal parts mixture of Ora-Plus and Ora-Sweet SF. The suspensions were packaged in amber plastic screw-cap prescription bottles, which were stored at 23°C for 21 days or 4°C for 60 days. Stability-indicating high-performance liquid chromatographic analysis revealed that the temozolomide concentration in both suspension vehicle combinations exhibited little or no loss for 60 days at 4°C. At 23°C, temozolomide losses were somewhat greater. In the Ora-Sweet formulation,

Related Keywords: Lawrence A. Trissel, BS, RPh, FASHP, Yanping Zhang, BS, Susannah E. Koontz, PharmD, BCOP, temozolomide, brain tumors, cancer chemotherapy, oral suspensions, liquid preparations, stability, storage, temperature, vehicles, formulation

Related Categories: CANCER AND AIDS, FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Trissel Lawrence A, Zhang Yanping, Koontz Susannah E Sep/Oct 2006 396-399 Buy
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr Mar/Apr 2004 126 Buy
Extended Stability of Oxytocin in Common Infusion Solutions Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric Mar/Apr 2006 156-158 Buy
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Trissel Lawrence A, Zhang Yanping Jul/Aug 2005 320-322 Buy
Oral Liquid Vehicles, Featured Excipient: Allen Loyd V Jr Jan/Feb 2001 65 Buy
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Trissel Lawrence A, Zhang Yanping May/Jun 2004 231-235 Buy
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Trissel Lawrence A, Zhang Yanping Sep/Oct 2004 398-403 Buy
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Ford Stephen M, Kloesel Lawson G, Grabenstein John D Mar/Apr 2007 164-176 Buy
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Trusley Craig, Kupiec Thomas C, Trissel Lawrence A May/Jun 2006 230-233 Buy
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A, Zhang Yanping May/Jun 2006 234-236 Buy